CRP and COVID-19: Similar conclusions can also be drawn from a recent study, where patients with SMD including schizophrenia who were hospitalised for severe COVID-19 had high levels of inflammatory biomarkers such as CRP, IL-6, D-dimer and ferritin, on admission (54, 55).